News coverage about Bruker Corporation (NASDAQ:BRKR) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bruker Corporation earned a daily sentiment score of 0.09 on Accern’s scale. Accern also assigned media coverage about the medical research company an impact score of 46.8908800301723 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Here are some of the news headlines that may have impacted Accern Sentiment’s analysis:

BRKR has been the topic of several recent analyst reports. Cowen and Company raised their price target on shares of Bruker Corporation from $25.00 to $27.00 and gave the stock a “market perform” rating in a research note on Thursday, May 4th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $29.00 price target on shares of Bruker Corporation in a research note on Friday, May 5th. Deutsche Bank AG raised their price target on shares of Bruker Corporation from $25.00 to $27.00 and gave the stock a “hold” rating in a research note on Friday, May 5th. Zacks Investment Research raised shares of Bruker Corporation from a “hold” rating to a “buy” rating and set a $33.00 price target on the stock in a research note on Thursday, July 6th. Finally, Wells Fargo & Company downgraded shares of Bruker Corporation from a “market perform” rating to an “underperform” rating in a research note on Wednesday, July 12th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. Bruker Corporation presently has an average rating of “Hold” and an average price target of $27.00.

Shares of Bruker Corporation (NASDAQ:BRKR) traded up 0.53% on Monday, reaching $28.50. 345,101 shares of the company’s stock traded hands. Bruker Corporation has a 52 week low of $19.58 and a 52 week high of $30.22. The firm has a market capitalization of $4.52 billion, a P/E ratio of 28.41 and a beta of 1.10. The firm’s 50 day moving average is $28.35 and its 200 day moving average is $25.99.

Bruker Corporation (NASDAQ:BRKR) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.03. Bruker Corporation had a return on equity of 26.66% and a net margin of 9.65%. The company had revenue of $414.90 million for the quarter, compared to the consensus estimate of $384.75 million. During the same period in the previous year, the business earned $0.20 EPS. Bruker Corporation’s revenue for the quarter was up 11.6% compared to the same quarter last year. Analysts expect that Bruker Corporation will post $1.12 earnings per share for the current fiscal year.

Bruker Corporation announced that its board has initiated a stock repurchase program on Friday, May 12th that allows the company to buyback $225.00 million in outstanding shares. This buyback authorization allows the medical research company to repurchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s leadership believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 22nd. Shareholders of record on Tuesday, September 5th will be issued a dividend of $0.04 per share. The ex-dividend date of this dividend is Thursday, August 31st. This represents a $0.16 annualized dividend and a yield of 0.56%. Bruker Corporation’s dividend payout ratio is presently 16.00%.

In other Bruker Corporation news, Director Richard Kniss sold 24,000 shares of Bruker Corporation stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $28.23, for a total transaction of $677,520.00. Following the sale, the director now directly owns 46,753 shares in the company, valued at approximately $1,319,837.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Mark Munch sold 73,724 shares of Bruker Corporation stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $27.62, for a total value of $2,036,256.88. Following the sale, the vice president now owns 106,602 shares in the company, valued at $2,944,347.24. The disclosure for this sale can be found here. Insiders have sold a total of 117,624 shares of company stock worth $3,271,574 over the last 90 days. 35.20% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This article was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/bruker-corporation-brkr-receiving-somewhat-favorable-media-coverage-accern-reports/1528516.html.

Bruker Corporation Company Profile

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

Insider Buying and Selling by Quarter for Bruker Corporation (NASDAQ:BRKR)

Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.